LG
Ligand Pharmaceuticals, Inc.
LGNXZ · OTC
$0.00 -55.56% (-$0.00)
1M -45.65%
Market Cap $90.2K
P/E Ratio 0.00x
Div. Yield -
ROE 20.06%
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/FCF 0.00x
P/E 0.00x
P/B 0.00x
Growth
77 /100
Growing Book val. growth 8.00%
Rev. growth 17.72%
FCF growth N/A
Profitability
100 /100
Strong Op. margin 34.45%
Gross margin 90.70%
FCF margin 45.24%
Quality
49 /100
Average ROA 9.02%
ROIC 3.88%
Asset turnover 0.13x
Debt
82 /100
Low Int. coverage 22.22x
Debt/Equity 1.17x
Net debt/EBITDA 0.72x
Stability
31 /100
Unstable EPS volatility 1,194.95%
Beta 0.98x
Profitable years 2
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na LGNXZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Nadcházející události
05 LIS
Earnings
Upcoming earnings report